These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 685692)

  • 21. Inactivation of ultraviolet repair in normal and xeroderma pigmentosum cells by methyl methanesulfonate.
    Cleaver JE
    Cancer Res; 1982 Mar; 42(3):860-3. PubMed ID: 7059984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant melanoma of the iris in xeroderma pigmentosum.
    Johnson MW; Skuta GL; Kincaid MC; Nelson CC; Wolter JR
    Arch Ophthalmol; 1989 Mar; 107(3):402-7. PubMed ID: 2923565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutational spectrum of Xeroderma pigmentosum group A in Egyptian patients.
    Amr K; Messaoud O; El Darouti M; Abdelhak S; El-Kamah G
    Gene; 2014 Jan; 533(1):52-6. PubMed ID: 24135642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Xeroderma pigmentosum: report of 6 cases in Dakar].
    Dieng MT; Niang SO; Dangou JM; Ndiaye B
    Bull Cancer; 2001 Feb; 88(2):199-202. PubMed ID: 11257594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The founding members of xeroderma pigmentosum group G produce XPG protein with severely impaired endonuclease activity.
    Lalle P; Nouspikel T; Constantinou A; Thorel F; Clarkson SG
    J Invest Dermatol; 2002 Feb; 118(2):344-51. PubMed ID: 11841555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [DNA repair in the UV irradiation of human peripheral blood lymphocytes (healthy donors and xeroderma pigmentosum patients) in relation to the dedifferentiation process in phytohemagglutinin exposure].
    Genter EI; Zhestianikov VD; Mikhel'son VM; Prokof'eva VV
    Tsitologiia; 1984 May; 26(5):599-604. PubMed ID: 6474576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A whole family affected by xeroderma pigmentosum: clinical and genetic particularities].
    Zghal M; Fazaa B; Zghal A; Mokhtar I; Sarasin A; Kamoun MR; Gharbi MR
    Ann Dermatol Venereol; 2003 Jan; 130(1 Pt 1):31-6. PubMed ID: 12605154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ocular changes in xeroderma pigmentosum (a case report).
    MATHUR SP
    Ophthalmologica; 1960 Jul; 140():33-6. PubMed ID: 13768153
    [No Abstract]   [Full Text] [Related]  

  • 29. Multiple cutaneous malignancies in a patient of xeroderma pigmentosum.
    Grampurohit VU; Dinesh US; Rao R
    J Cancer Res Ther; 2011; 7(2):205-7. PubMed ID: 21768716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Germline and somatic mutations of the INK4a-ARF gene in a xeroderma pigmentosum group C patient.
    Soufir N; Ribojad M; Magnaldo T; Thibaudeau O; Delestaing G; Daya-Grosjean L; Rivet J; Sarasin A; Basset-Seguin N
    J Invest Dermatol; 2002 Dec; 119(6):1355-60. PubMed ID: 12485439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultraviolet-B-induced apoptosis and cytokine release in xeroderma pigmentosum keratinocytes.
    Petit-Frère C; Capulas E; Lowe JE; Koulu L; Marttila RJ; Jaspers NG; Clingen PH; Green MH; Arlett CF
    J Invest Dermatol; 2000 Oct; 115(4):687-93. PubMed ID: 10998144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Xeroderma pigmentosum: a review and case series.
    Butt FM; Moshi JR; Owibingire S; Chindia ML
    J Craniomaxillofac Surg; 2010 Oct; 38(7):534-7. PubMed ID: 20346687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Penetrating keratoplasty in xeroderma pigmentosum. Case reports and review of the literature.
    Jalali S; Boghani S; Vemuganti GK; Ratnakar KS; Rao GN
    Cornea; 1994 Nov; 13(6):527-33. PubMed ID: 7842713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Group D xeroderma pigmentosum: a case with a number of nevocellular nevi.
    Inoue Y; Yamaizumi M; Ono T
    J Dermatol; 1995 May; 22(5):360-4. PubMed ID: 7673558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Absence of adaptive DNA repair in xeroderma pigmentosum cells].
    Vasil'eva IM; Sinel'shchikova TA; L'vova GN; Meliksetova IA; Zasukhina GD
    Genetika; 1994 Apr; 30(4):484-7. PubMed ID: 8045399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 10-year follow-up of a child with mild case of xeroderma pigmentosum complementation group D diagnosed by whole-genome sequencing.
    Ono R; Masaki T; Mayca Pozo F; Nakazawa Y; Swagemakers SM; Nakano E; Sakai W; Takeuchi S; Kanda F; Ogi T; van der Spek PJ; Sugasawa K; Nishigori C
    Photodermatol Photoimmunol Photomed; 2016 Jul; 32(4):174-80. PubMed ID: 26993158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The comet assay as a repair test for prenatal diagnosis of Xeroderma pigmentosum and trichothiodystrophy.
    Alapetite C; Benoit A; Moustacchi E; Sarasin A
    J Invest Dermatol; 1997 Feb; 108(2):154-9. PubMed ID: 9008227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Xeroderma pigmentosum with repeated facial skin carcinogenesis: report of one case].
    Li F; Jiang YH; Zhan SL
    Shanghai Kou Qiang Yi Xue; 2012 Aug; 21(4):478-80. PubMed ID: 23135130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Normal rate of DNA breakage in xeroderma pigmentosum complementation group E cells treated with 8-methoxypsoralen plus near-ultraviolet radiation.
    Bredberg A; Söderhäll S
    Biochim Biophys Acta; 1985 Mar; 824(3):268-71. PubMed ID: 3970936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A child with xeroderma pigmentosum and bone marrow failure.
    Salob SP; Webb DK; Atherton DJ
    Br J Dermatol; 1992 Apr; 126(4):372-4. PubMed ID: 1571258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.